The global Pediatrics Medicine market was valued at US$ 161810 million in 2023 and is anticipated to reach US$ 216370 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

Pediatrics Medicine Market

Pediatrics (also spelled paediatrics or pædiatrics) is the branch of medicine that involves the medical care of infants, children, and adolescents.This report anzlyed the medicines for pediatrics.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pediatrics Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatrics Medicine.

Report Scope

The Pediatrics Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatrics Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pediatrics Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pediatrics Medicine Market Report

Report Metric	Details
Report Name	Pediatrics Medicine Market
Accounted market size in 2023	US$ 161810 million
Forecasted market size in 2030	US$ 216370 million
CAGR	4.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tablets Caplets Oral Liquid Capsules Other
Segment by Application	Respiratory diseases Infectious diseases Gastrointestinal diseases CNS diseases Oncological diseases CVDs Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novartis, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories, Lupin Pharmaceuticals, Merck Sharp & Dohme, RedHill, Sun Pharmaceutical Industries, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatrics Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pediatrics Medicine Market growing?

Ans: The Pediatrics Medicine Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Pediatrics Medicine Market size in 2030?

Ans: The Pediatrics Medicine Market size in 2030 will be US$ 216370 million.

Who are the main players in the Pediatrics Medicine Market report?

Ans: The main players in the Pediatrics Medicine Market are GSK, Novartis, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals, Eli Lilly, F. Hoffman-La Roche, Glenmark, Helsinn Healthcare, Heron Therapeutics, Ipca Laboratories, Lupin Pharmaceuticals, Merck Sharp & Dohme, RedHill, Sun Pharmaceutical Industries, Takeda Pharmaceutical

What are the Application segmentation covered in the Pediatrics Medicine Market report?

Ans: The Applications covered in the Pediatrics Medicine Market report are Respiratory diseases, Infectious diseases, Gastrointestinal diseases, CNS diseases, Oncological diseases, CVDs, Others

What are the Type segmentation covered in the Pediatrics Medicine Market report?

Ans: The Types covered in the Pediatrics Medicine Market report are Tablets, Caplets, Oral Liquid, Capsules, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Tablets

1.2.3 Caplets

1.2.4 Oral Liquid

1.2.5 Capsules

1.2.6 Other

1.3 Market by Application

1.3.1 Global Pediatrics Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Respiratory diseases

1.3.3 Infectious diseases

1.3.4 Gastrointestinal diseases

1.3.5 CNS diseases

1.3.6 Oncological diseases

1.3.7 CVDs

1.3.8 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pediatrics Medicine Market Perspective (2019-2030)

2.2 Pediatrics Medicine Growth Trends by Region

2.2.1 Global Pediatrics Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pediatrics Medicine Historic Market Size by Region (2019-2024)

2.2.3 Pediatrics Medicine Forecasted Market Size by Region (2025-2030)

2.3 Pediatrics Medicine Market Dynamics

2.3.1 Pediatrics Medicine Industry Trends

2.3.2 Pediatrics Medicine Market Drivers

2.3.3 Pediatrics Medicine Market Challenges

2.3.4 Pediatrics Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pediatrics Medicine Players by Revenue

3.1.1 Global Top Pediatrics Medicine Players by Revenue (2019-2024)

3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pediatrics Medicine Revenue

3.4 Global Pediatrics Medicine Market Concentration Ratio

3.4.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2023

3.5 Pediatrics Medicine Key Players Head office and Area Served

3.6 Key Players Pediatrics Medicine Product Solution and Service

3.7 Date of Enter into Pediatrics Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatrics Medicine Breakdown Data by Type

4.1 Global Pediatrics Medicine Historic Market Size by Type (2019-2024)

4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030)

5 Pediatrics Medicine Breakdown Data by Application

5.1 Global Pediatrics Medicine Historic Market Size by Application (2019-2024)

5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pediatrics Medicine Market Size (2019-2030)

6.2 North America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pediatrics Medicine Market Size by Country (2019-2024)

6.4 North America Pediatrics Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pediatrics Medicine Market Size (2019-2030)

7.2 Europe Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pediatrics Medicine Market Size by Country (2019-2024)

7.4 Europe Pediatrics Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pediatrics Medicine Market Size (2019-2030)

8.2 Asia-Pacific Pediatrics Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pediatrics Medicine Market Size (2019-2030)

9.2 Latin America Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pediatrics Medicine Market Size by Country (2019-2024)

9.4 Latin America Pediatrics Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pediatrics Medicine Market Size (2019-2030)

10.2 Middle East & Africa Pediatrics Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Detail

11.1.2 GSK Business Overview

11.1.3 GSK Pediatrics Medicine Introduction

11.1.4 GSK Revenue in Pediatrics Medicine Business (2019-2024)

11.1.5 GSK Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Pediatrics Medicine Introduction

11.2.4 Novartis Revenue in Pediatrics Medicine Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Pediatrics Medicine Introduction

11.3.4 Pfizer Revenue in Pediatrics Medicine Business (2019-2024)

11.3.5 Pfizer Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Detail

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Pediatrics Medicine Introduction

11.4.4 Sanofi Revenue in Pediatrics Medicine Business (2019-2024)

11.4.5 Sanofi Recent Development

11.5 Abbott

11.5.1 Abbott Company Detail

11.5.2 Abbott Business Overview

11.5.3 Abbott Pediatrics Medicine Introduction

11.5.4 Abbott Revenue in Pediatrics Medicine Business (2019-2024)

11.5.5 Abbott Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Detail

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction

11.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Cipla

11.7.1 Cipla Company Detail

11.7.2 Cipla Business Overview

11.7.3 Cipla Pediatrics Medicine Introduction

11.7.4 Cipla Revenue in Pediatrics Medicine Business (2019-2024)

11.7.5 Cipla Recent Development

11.8 Eisai Pharmaceuticals

11.8.1 Eisai Pharmaceuticals Company Detail

11.8.2 Eisai Pharmaceuticals Business Overview

11.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction

11.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)

11.8.5 Eisai Pharmaceuticals Recent Development

11.9 Eli Lilly

11.9.1 Eli Lilly Company Detail

11.9.2 Eli Lilly Business Overview

11.9.3 Eli Lilly Pediatrics Medicine Introduction

11.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024)

11.9.5 Eli Lilly Recent Development

11.10 F. Hoffman-La Roche

11.10.1 F. Hoffman-La Roche Company Detail

11.10.2 F. Hoffman-La Roche Business Overview

11.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction

11.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024)

11.10.5 F. Hoffman-La Roche Recent Development

11.11 Glenmark

11.11.1 Glenmark Company Detail

11.11.2 Glenmark Business Overview

11.11.3 Glenmark Pediatrics Medicine Introduction

11.11.4 Glenmark Revenue in Pediatrics Medicine Business (2019-2024)

11.11.5 Glenmark Recent Development

11.12 Helsinn Healthcare

11.12.1 Helsinn Healthcare Company Detail

11.12.2 Helsinn Healthcare Business Overview

11.12.3 Helsinn Healthcare Pediatrics Medicine Introduction

11.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024)

11.12.5 Helsinn Healthcare Recent Development

11.13 Heron Therapeutics

11.13.1 Heron Therapeutics Company Detail

11.13.2 Heron Therapeutics Business Overview

11.13.3 Heron Therapeutics Pediatrics Medicine Introduction

11.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024)

11.13.5 Heron Therapeutics Recent Development

11.14 Ipca Laboratories

11.14.1 Ipca Laboratories Company Detail

11.14.2 Ipca Laboratories Business Overview

11.14.3 Ipca Laboratories Pediatrics Medicine Introduction

11.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024)

11.14.5 Ipca Laboratories Recent Development

11.15 Lupin Pharmaceuticals

11.15.1 Lupin Pharmaceuticals Company Detail

11.15.2 Lupin Pharmaceuticals Business Overview

11.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction

11.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024)

11.15.5 Lupin Pharmaceuticals Recent Development

11.16 Merck Sharp & Dohme

11.16.1 Merck Sharp & Dohme Company Detail

11.16.2 Merck Sharp & Dohme Business Overview

11.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction

11.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024)

11.16.5 Merck Sharp & Dohme Recent Development

11.17 RedHill

11.17.1 RedHill Company Detail

11.17.2 RedHill Business Overview

11.17.3 RedHill Pediatrics Medicine Introduction

11.17.4 RedHill Revenue in Pediatrics Medicine Business (2019-2024)

11.17.5 RedHill Recent Development

11.18 Sun Pharmaceutical Industries

11.18.1 Sun Pharmaceutical Industries Company Detail

11.18.2 Sun Pharmaceutical Industries Business Overview

11.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction

11.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024)

11.18.5 Sun Pharmaceutical Industries Recent Development

11.19 Takeda Pharmaceutical

11.19.1 Takeda Pharmaceutical Company Detail

11.19.2 Takeda Pharmaceutical Business Overview

11.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction

11.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024)

11.19.5 Takeda Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eisai Pharmaceuticals

Lupin Pharmaceuticals

Merck Sharp & Dohme

Redhill

Sun Pharmaceutical Industries

Takeda Pharmaceutical

List of Tables

Table 1. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Tablets

Table 3. Key Players of Caplets

Table 4. Key Players of Oral Liquid

Table 5. Key Players of Capsules

Table 6. Key Players of Other

Table 7. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Pediatrics Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Pediatrics Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Pediatrics Medicine Market Share by Region (2019-2024)

Table 11. Global Pediatrics Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Pediatrics Medicine Market Share by Region (2025-2030)

Table 13. Pediatrics Medicine Market Trends

Table 14. Pediatrics Medicine Market Drivers

Table 15. Pediatrics Medicine Market Challenges

Table 16. Pediatrics Medicine Market Restraints

Table 17. Global Pediatrics Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Pediatrics Medicine Market Share by Players (2019-2024)

Table 19. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2023)

Table 20. Ranking of Global Top Pediatrics Medicine Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Pediatrics Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Pediatrics Medicine Product Solution and Service

Table 24. Date of Enter into Pediatrics Medicine Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Pediatrics Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Pediatrics Medicine Revenue Market Share by Type (2019-2024)

Table 28. Global Pediatrics Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Pediatrics Medicine Revenue Market Share by Type (2025-2030)

Table 30. Global Pediatrics Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Pediatrics Medicine Revenue Market Share by Application (2019-2024)

Table 32. Global Pediatrics Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Pediatrics Medicine Revenue Market Share by Application (2025-2030)

Table 34. North America Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Pediatrics Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Pediatrics Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Pediatrics Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Pediatrics Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Pediatrics Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Pediatrics Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 49. GSK Company Detail

Table 50. GSK Business Overview

Table 51. GSK Pediatrics Medicine Product

Table 52. GSK Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 53. GSK Recent Development

Table 54. Novartis Company Detail

Table 55. Novartis Business Overview

Table 56. Novartis Pediatrics Medicine Product

Table 57. Novartis Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Pfizer Company Detail

Table 60. Pfizer Business Overview

Table 61. Pfizer Pediatrics Medicine Product

Table 62. Pfizer Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 63. Pfizer Recent Development

Table 64. Sanofi Company Detail

Table 65. Sanofi Business Overview

Table 66. Sanofi Pediatrics Medicine Product

Table 67. Sanofi Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 68. Sanofi Recent Development

Table 69. Abbott Company Detail

Table 70. Abbott Business Overview

Table 71. Abbott Pediatrics Medicine Product

Table 72. Abbott Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 73. Abbott Recent Development

Table 74. Bristol-Myers Squibb Company Detail

Table 75. Bristol-Myers Squibb Business Overview

Table 76. Bristol-Myers Squibb Pediatrics Medicine Product

Table 77. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 78. Bristol-Myers Squibb Recent Development

Table 79. Cipla Company Detail

Table 80. Cipla Business Overview

Table 81. Cipla Pediatrics Medicine Product

Table 82. Cipla Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 83. Cipla Recent Development

Table 84. Eisai Pharmaceuticals Company Detail

Table 85. Eisai Pharmaceuticals Business Overview

Table 86. Eisai Pharmaceuticals Pediatrics Medicine Product

Table 87. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 88. Eisai Pharmaceuticals Recent Development

Table 89. Eli Lilly Company Detail

Table 90. Eli Lilly Business Overview

Table 91. Eli Lilly Pediatrics Medicine Product

Table 92. Eli Lilly Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 93. Eli Lilly Recent Development

Table 94. F. Hoffman-La Roche Company Detail

Table 95. F. Hoffman-La Roche Business Overview

Table 96. F. Hoffman-La Roche Pediatrics Medicine Product

Table 97. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 98. F. Hoffman-La Roche Recent Development

Table 99. Glenmark Company Detail

Table 100. Glenmark Business Overview

Table 101. Glenmark Pediatrics Medicine Product

Table 102. Glenmark Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 103. Glenmark Recent Development

Table 104. Helsinn Healthcare Company Detail

Table 105. Helsinn Healthcare Business Overview

Table 106. Helsinn Healthcare Pediatrics Medicine Product

Table 107. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 108. Helsinn Healthcare Recent Development

Table 109. Heron Therapeutics Company Detail

Table 110. Heron Therapeutics Business Overview

Table 111. Heron Therapeutics Pediatrics Medicine Product

Table 112. Heron Therapeutics Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 113. Heron Therapeutics Recent Development

Table 114. Ipca Laboratories Company Detail

Table 115. Ipca Laboratories Business Overview

Table 116. Ipca Laboratories Pediatrics Medicine Product

Table 117. Ipca Laboratories Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 118. Ipca Laboratories Recent Development

Table 119. Lupin Pharmaceuticals Company Detail

Table 120. Lupin Pharmaceuticals Business Overview

Table 121. Lupin Pharmaceuticals Pediatrics Medicine Product

Table 122. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 123. Lupin Pharmaceuticals Recent Development

Table 124. Merck Sharp & Dohme Company Detail

Table 125. Merck Sharp & Dohme Business Overview

Table 126. Merck Sharp & Dohme Pediatrics Medicine Product

Table 127. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 128. Merck Sharp & Dohme Recent Development

Table 129. RedHill Company Detail

Table 130. RedHill Business Overview

Table 131. RedHill Pediatrics Medicine Product

Table 132. RedHill Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 133. RedHill Recent Development

Table 134. Sun Pharmaceutical Industries Company Detail

Table 135. Sun Pharmaceutical Industries Business Overview

Table 136. Sun Pharmaceutical Industries Pediatrics Medicine Product

Table 137. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 138. Sun Pharmaceutical Industries Recent Development

Table 139. Takeda Pharmaceutical Company Detail

Table 140. Takeda Pharmaceutical Business Overview

Table 141. Takeda Pharmaceutical Pediatrics Medicine Product

Table 142. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2019-2024) & (US$ Million)

Table 143. Takeda Pharmaceutical Recent Development

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pediatrics Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pediatrics Medicine Market Share by Type: 2023 VS 2030

Figure 3. Tablets Features

Figure 4. Caplets Features

Figure 5. Oral Liquid Features

Figure 6. Capsules Features

Figure 7. Other Features

Figure 8. Global Pediatrics Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Pediatrics Medicine Market Share by Application: 2023 VS 2030

Figure 10. Respiratory diseases Case Studies

Figure 11. Infectious diseases Case Studies

Figure 12. Gastrointestinal diseases Case Studies

Figure 13. CNS diseases Case Studies

Figure 14. Oncological diseases Case Studies

Figure 15. CVDs Case Studies

Figure 16. Others Case Studies

Figure 17. Pediatrics Medicine Report Years Considered

Figure 18. Global Pediatrics Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Pediatrics Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Pediatrics Medicine Market Share by Region: 2023 VS 2030

Figure 21. Global Pediatrics Medicine Market Share by Players in 2023

Figure 22. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatrics Medicine as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2023

Figure 24. North America Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Pediatrics Medicine Market Share by Country (2019-2030)

Figure 26. United States Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Pediatrics Medicine Market Share by Country (2019-2030)

Figure 30. Germany Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Pediatrics Medicine Market Share by Region (2019-2030)

Figure 38. China Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Pediatrics Medicine Market Share by Country (2019-2030)

Figure 46. Mexico Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Pediatrics Medicine Market Share by Country (2019-2030)

Figure 50. Turkey Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Pediatrics Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. GSK Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 53. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 54. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 55. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 56. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 58. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 59. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 60. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 61. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 62. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 63. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 64. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 65. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 67. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 68. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 69. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 70. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-20G14329

Thu May 02 00:00:00 UTC 2024

Add to Cart

Global Nocturia Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39M10215

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Medicine Treat BPH Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33F12613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Neurorehabilitation Gaming Systems Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E10017

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pediatrics Medicine Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-27B2659

Global Pediatrics Medicine Market Research Report 2024

FEATURED COMPANIES

Pediatrics Medicine Market Size

Pediatrics Medicine Market

Report Scope

Scope of Pediatrics Medicine Market Report

Chapter Outline

FAQ for this report

How fast is Pediatrics Medicine Market growing?

What is the Pediatrics Medicine Market size in 2030?

Who are the main players in the Pediatrics Medicine Market report?

What are the Application segmentation covered in the Pediatrics Medicine Market report?

What are the Type segmentation covered in the Pediatrics Medicine Market report?

FEATURED COMPANIES

RELATED REPORTS